Sarepta stock climbs. 3-year study results for Elevidys bring hope

Sarepta’s blockbuster gene therapy has come under scrutiny following a string of patient deaths.

Sarepta's Duchenne gene therapy slows disease progression at three years

By Mariam Sunny Jan 26 (Reuters) - Sarepta Therapeutics' gene therapy for Duchenne muscular dystrophy slowed disease ...
KSDK

'You won't be alone': Families unite at Forest Park for MDA Muscle Walk

ST. LOUIS — On a cloudy morning in Forest Park, families gathered not just to take steps together but to take them for each other. The Muscular Dystrophy Association's 2025 Muscle Walk on May 4 drew ...
Manistee News Advocate on MSN

AMISH KITCHEN: Daughter Verena discusses her disability

"Muscular dystrophy can take many things from me, but it will not take away my happiness, nor will it take away my faith." ...